Cary Caldwell, MD
Research & Publications
Biography
Research Summary
Dr. Caldwell's clinical interest and publications include hepatic myelopathy, hepatic repercussion injury, cytokines in liver disease, alcohol liver disease, fulminant hepatic failure, recurrent hepatitis C post liver transplantation, hepatitis B association with Hodgkin's lymphoma and the screening of hepatocellular carcinoma.
Coauthors
Research Interests
Esophageal and Gastric Varices; Fatty Liver, Alcoholic; Hepatic Encephalopathy; Carcinoma, Hepatocellular; Liver Failure, Acute; Hepatitis, Autoimmune; Hepatitis B, Chronic; Hepatitis C, Chronic; Hepatopulmonary Syndrome; End Stage Liver Disease; Non-alcoholic Fatty Liver Disease
Selected Publications
- Use of model for end-stage liver disease exception points for early liver transplantation and successful reversal of hepatic myelopathy with a review of the literature.Caldwell C, Werdiger N, Jakab S, Schilsky M, Arvelakis A, Kulkarni S, Emre S. Use of model for end-stage liver disease exception points for early liver transplantation and successful reversal of hepatic myelopathy with a review of the literature. Liver Transplantation : Official Publication Of The American Association For The Study Of Liver Diseases And The International Liver Transplantation Society 2010, 16:818-26.
- Hepatitis E virus infection in a liver transplant recipient: delayed diagnosis due to variable performance of serologic assays.Yoo N, Bernstein J, Caldwell C, Dong C, Drobeniuc J, Kamili S, Landry ML. Hepatitis E virus infection in a liver transplant recipient: delayed diagnosis due to variable performance of serologic assays. Transplant Infectious Disease : An Official Journal Of The Transplantation Society 2013, 15:E166-8.
- Successful treatment of fibrosing cholestatic hepatitis after liver transplantation.Cimsit B, Assis D, Caldwell C, Arvelakis A, Taddei T, Kulkarni S, Schilsky M, Emre S. Successful treatment of fibrosing cholestatic hepatitis after liver transplantation. Transplantation Proceedings 2011, 43:905-8.
- Incidence of non-Hodgkin's lymphoma among individuals with chronic hepatitis B virus infection.Ulcickas Yood M, Quesenberry CP, Guo D, Caldwell C, Wells K, Shan J, Sanders L, Skovron ML, Iloeje U, Manos MM. Incidence of non-Hodgkin's lymphoma among individuals with chronic hepatitis B virus infection. Hepatology (Baltimore, Md.) 2007, 46:107-12.
- Etiology and outcome for 295 patients with acute liver failure in the United States.Schiodt FV, Atillasoy E, Shakil AO, Schiff ER, Caldwell C, Kowdley KV, Stribling R, Crippin JS, Flamm S, Somberg KA, Rosen H, McCashland TM, Hay JE, Lee WM. Etiology and outcome for 295 patients with acute liver failure in the United States. Liver Transplantation And Surgery : Official Publication Of The American Association For The Study Of Liver Diseases And The International Liver Transplantation Society 1999, 5:29-34.
- Successful treatment of hyperammonemia after lung transplantation.Rueda JF, Caldwell C, Brennan DC. Successful treatment of hyperammonemia after lung transplantation. Annals Of Internal Medicine 1998, 128:956-7.
- Incidence of hepatocellular carcinoma among individuals with hepatitis B virus infection identified using an automated data algorithm.Ulcickas Yood M, Quesenberry CP, Guo D, Wells K, Shan J, Sanders L, Skovron ML, Iloeje U, Caldwell C, Manos MM. Incidence of hepatocellular carcinoma among individuals with hepatitis B virus infection identified using an automated data algorithm. Journal Of Viral Hepatitis 2008, 15:28-36.